Could This Patent Decision Surprise Teva Bears?

By: via Benzinga
Morgan Stanley’s David Risinger maintained an Overweight rating on Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA), with ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.